title: Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension.
abstract: OBJECTIVE
  To study the cardiovascular effects of hydrocortisone in preterm infants with hypotension unresponsive to volume and pressor administration.
  
  
  METHODS
  Retrospective review of the cardiovascular response to 23 courses of hydrocortisone administration during the first day of treatment in 21 preterm infants (gestational age: 26.9 +/- 3.9 weeks; postnatal age: 11.3 +/- 13.1 days). Hydrocortisone (2 mg/kg/d in 16 patients and 3-6 mg/kg/d in 5 patients) was administered when dopamine (22.2 +/- 11 microg/kg/min, range: 8-60) alone (n = 16) or in combination with dobutamine (8.4 +/- 4.9 microg/kg/min, range: 5-20, n = 7) and/or epinephrine (0.38 +/- 0.56 microg/kg/min, range: 0.01-1.2, n = 4) failed to normalize blood pressure.
  
  
  RESULTS
  Mean blood pressure increased from 29.3 +/- 4.1 to 34.1 +/- 5.2, 38.0 +/- 8.0, and 41.8 +/- 6.6 mm Hg by 2, 4, and 6 hours of hydrocortisone administration, respectively, and remained stable thereafter. Urine output increased despite a decrease in fluid administration during the first day of hydrocortisone treatment. The dose of dopamine and the number of patients receiving dobutamine and/or epinephrine also decreased during the same period. Eighteen of the 21 patients survived.
  
  
  CONCLUSIONS
  Preterm infants with volume- and pressor-resistant hypotension respond to hydrocortisone with rapid normalization of the cardiovascular status and sustained decreases in volume and pressor requirement.
authors.affiliation: Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. seri@email.chop.edu
authors.forename: I
authors.initials: I
authors.lastname: Seri
authors.forename: R
authors.initials: R
authors.lastname: Tan
authors.forename: J
authors.initials: J
authors.lastname: Evans
mesh_terms: D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects*; D002316:Cardiotonic Agents / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D007022:Hypotension / Q000503:physiopathology / Q000628:therapy*; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000628:therapy*; D012189:Retrospective Studies; D017211:Treatment Failure
chemical_list: D001786:Blood Glucose; D002316:Cardiotonic Agents; D004298:Dopamine; D006854:Hydrocortisone